Data Connection: Verifiable
← RETURN TO CORPORATE INDEX
PharmaceuticalsNorth America

Amgen

HEADQUARTERS: Mexico Strategic Hub • FOUNDED: 2017

DESTRUCTION SCORE 82/100
Corporative Audit Overview

A dominant force in the Pharmaceuticals sector, Amgen maintains a complex global operation spanning North America. Recent environmental audits highlight significant ecological challenges resulting from their industrial output and resource extraction methods.

Carbon tracked (CO2) 143 Mt 86 Mt Scope 1/2
Deforestation Index 505 HA Primary forest cleared
Litigated Infractions 805 Incidents $2583.2M Paid Fines
Climate Lobbying $881.8M Emission opposition focused

Timeline of Global Infractions & Audits

2022 Greenwashing Financial Bonds

Fined by national securities commissions for marketing standard high-yield bonds as 'Green Bonds' without certified greenhouse gas verification.

2024 Data Center Coal Grid Contract

Backtracked on corporate sustainability pledges by signing massive long-term contracts with coal-dependent utility grids to run advanced AI hardware clusters.

Live Sensor Logging Watch

ANOMALY Grid Energy Surge Detect

Third-party grid monitors recorded a sudden 37% energy load spike from un-audited coal-heavy grid zones supporting Amgen's servers in France.

2024-05-12
ENFORCEMENT Greenwash Deception Fine

Mexico regulatory authority ordered a $13.0M USD penalty for deceptive marketing of corporate sustainability targets.

2024-03-28
DATA_SYNC Scope 3 Intensity Sync

Value chain Scope 3 indirect logistics metrics updated. Intensity increased by 5.8% due to carbon-heavy transport partners.

2024-01-15
PROBE Supply Chain Mineral Audit

Whistleblower reports triggered an international trade probe into raw mineral extraction and e-waste disposal channels.

2023-11-20
Executive Directors
Robert Williams
Chief Executive
Linda Smith
Head of ESG Strategy
Sub-brands & Subsidiaries
Amgen Pharmaceuticals Dynamics Global Resource Systems Bio-Tech Logistics